期刊文献+

柴胡皂苷d对人肝细胞L-O2体外毒性机制探讨 被引量:21

Hepatotoxicity and its mechanism of saikosaponin d on the human liver L-O2 cells in vitro
下载PDF
导出
摘要 目的:考察柴胡主要成分之一柴胡皂苷d(ssd)体外肝毒性以及主要机制。方法:通过MTT试验、细胞形态学改变、DNAladder、DAPI荧光染色法、乳酸脱氢酶释放率、溶血试验等方法考察ssd对人肝细胞L-O2是否具有毒性作用,进而阐明ssd肝毒性产生的可能机制。结果:MTT法测得ssd的半抑制浓度(IC50)为2.44μmol/L,5μmol/L处理组细胞形态学发生明显改变,乳酸脱氢酶释放率增高和溶血试验结果发现毒性作用呈剂量依赖性,但DNAladder和DAPI荧光检测均未见明显细胞凋亡。结论:ssd具有较强的体外肝毒性,其机制可能是由于ssd诱导细胞膜通透性增加从而导致细胞损伤或坏死,而不是诱导细胞凋亡。 AIM:This study was to determine whether saikosaponin d (ssd) caused hepatotoxicity and to investigate the possible toxicity mechanism. METHODS: Experiment was carried out using the human live cell lines (L-O2) in vitro. MTT assay, change of cellular morphology, DNA fragmentation analysis, nuclear staining with 4, 6-diamidino-2-phenylindole (DAPI), hemolysis assay and membrane leakage of lactate dehydrogenase (LDH assay) were adopted to evaluate the hepatotoxicity of ssd. RESULTS: Results showed that L-O2 cells were inhibited significantly by above 2.5 μmol/L ssd, and IC50 = 2.44 μmol/L. The change of celluar morphology, increase of LDH release and hemolytic ratio ( % ) could be detected significantly when treated with 5 μmol/L ssd. However, other results showed no obvious induction on the apoptosis from DNA ladder and DAPI. CONCLUSION: The toxicity mechanism of ssd on the L-O2 cells in vitro might be not through apoptosis, but related to the cytolysis.
出处 《中国临床药理学与治疗学》 CAS CSCD 2007年第4期396-400,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家"十五"科技攻关计划课题(柴胡及其复方安全性评价示范研究)资助(2004BA721A15)
关键词 柴胡皂苷D L-O2肝细胞 体外肝毒性 saikosaponin d huamn liver cell L-O2 hepatotoxicity in vitro
  • 相关文献

参考文献1

二级参考文献19

  • 1Puente N, Valmori D, Ruegg C. The alternatively spliced domain TnFnlII A 1 A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production. J Immunol 2001; 167:6431-40.
  • 2Rosenberg SA. Identification of cancer antigens: impact on development of cancer immunotherapies. Cancer J Sci Am 2000; 6 Suppl 3: S200-S207.
  • 3Cheever MA, Greenberg PD, Fefer A, Gillis S. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. J Exp Med 1982; 155: 968-80.
  • 4Dong Y, Kwan CY, Chen ZN, Yang MM. Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor: in vitro and in vivo studies. Res Commun Mol Pathol Pharmacol 1996; 92: 140-8.
  • 5Dong Y, Yang MM, Kwan CY. In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs. Life Sci 1997;60: L135-40.
  • 6Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000; 5: 4-27.
  • 7Li XY. Immunomodulating Chinese herbal medicines. Mem Inst Oswaldo Cruz 1991; 86 Suppl 2: 159-64.
  • 8Mao XW, Archambeau JO, Gridley DS. Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor. Cancer Biother Radiopharm 1996; 11: 393-403.
  • 9Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 1998; 30: 1-4.
  • 10Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 2000;7: 715-29.

共引文献3

同被引文献407

引证文献21

二级引证文献314

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部